11/06/2025 | Press release | Distributed by Public on 11/06/2025 09:52
The Dayton Daily News spoke with the University of Cincinnati's Joseph Broderick to discuss a recent article he published in the journal Stroke examining the past, present and future of stroke care.
In 1975, when Broderick was a sophomore undergraduate, there were zero scientifically approved treatments for acute stroke.
Over his more than 40 years as a researcher and clinician, Broderick has actively contributed to major improvements in stroke care, occupying a front row seat to seismic innovations: the clinical trials that proved tPA as the first effective treatment for acute ischemic stroke in the 1990s, the seminal trials leading to mechanical removal of clots within the artery in the 2000s and most recently the FASTEST trial today testing what could be the first treatment to slow bleeding for spontaneous acute intracerebral hemorrhage (ICH).
In Broderick's vision of the future, stroke diagnosis will often begin before the patient ever reaches the hospital. Wearable technology and at-home monitoring could alert emergency responders to stroke symptoms in real time, allowing treatment to start en route.
"But no matter how advanced we get, time will always be the single most important factor for success," Broderick, MD, professor in the University of Cincinnati's College of Medicine, senior adviser at the UC Gardner Neuroscience Institute and director of the NIH StrokeNet National Coordinating Center told the Dayton Daily News.
"The next century will be about advances in recovery and rehabilitation after stroke and addressing current global disparities in stroke incidence, outcomes and access to proven therapies," Broderick continued. "We've made a significant dent in the burden of stroke over the past 50 years," he said. "And I think the best is yet to come."
Read the Dayton Daily News article.
Read more about the Broderick's predictions for 2050.
Featured photo at top of Dr. Broderick. Photo/Joseph Fuqua II/University of Cincinnati
January 9, 2024
A new trial at the University of Cincinnati Gardner Neuroscience Institute, funded by a $660,000 National Institutes of Health (NIH) grant, will test an at-home tongue endurance exercise to improve patients' swallowing function after a stroke.
May 5, 2023
The University of Cincinnati's Soma Sengupta was a co-first author on research published in Cell Reports Medicine New that found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor.
October 16, 2023
A collaborative team led by University of Cincinnati, University of North Carolina and Duke University researchers is studying how specific cancers and treatments affect patients' risk of stroke.